Company News, Regulations

New FDA Warning Letter

NJ-based firm cited for violation of Federal Food, Drug, and Cosmetic Act and insanitary practices.

Author Image

By: Christine Esposito

Editor-in-Chief

The US FDA has sent a warning letter to Haddonfield, NJ-based Reviva Labs, Inc.   Upon reviewing the firm’s cosmetic product labels following an October 2015 inspection and on its website in March 2016, FDA determined that company claims establish the firm’s Nasolabial Fold Multi-Peptide Cream, Glycolic Acid Oily Skin Daytime Light Cream Moisturizer, Skin Lightener For Day Fade Cream, DMAE Firming Fluid, Collagen Regeneration Cream, Lighten & Brighten Dark Spot Serum, Spider Vein & R...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters